Evidence map›Paper›PMID 34572396›Full record

ArticleBiomedicines2021

Serum Perilipin 2 (PLIN2) Predicts Multiple Organ Dysfunction in Critically Ill Patients.

Berkan Kurt, Lukas Buendgens, Theresa H Wirtz, Sven H Loosen, Maximilian Schulze-Hagen, Daniel Truhn, Jonathan F Brozat, Samira Abu Jhaisha, Philipp Hohlstein, Ger Koek and 5 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Perilipins at a glance.Journal of cell science · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Berkan KurtDepartment of Medicine III, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
Lukas BuendgensDepartment of Medicine III, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
Theresa H WirtzDepartment of Medicine III, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
Sven H LoosenClinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Moorenstaße 5, 40225 Düsseldorf, Germany.ORCID 0000-0002-2799-2287
Maximilian Schulze-HagenDepartment of Diagnostic and Interventional Radiology, University Hospital of RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.ORCID 0000-0002-9182-2688
Daniel TruhnDepartment of Diagnostic and Interventional Radiology, University Hospital of RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
Jonathan F BrozatDepartment of Medicine III, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
Samira Abu JhaishaDepartment of Medicine III, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
Philipp HohlsteinDepartment of Medicine III, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.ORCID 0000-0002-0796-8386
Ger KoekDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Maastricht University Medical Centre (MUMC), 6229 HX Maastricht, The Netherlands.
Ralf WeiskirchenInstitute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), University Hospital of RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.ORCID 0000-0003-3888-0931
Christian TrautweinDepartment of Medicine III, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
Frank TackeDepartment of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.ORCID 0000-0001-6206-0226
Karim HameschDepartment of Medicine III, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.ORCID 0000-0002-1702-2746
Alexander KochDepartment of Medicine III, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
RWTH Aachen University · DECharité - Universitätsmedizin Berlin · DEDüsseldorf University Hospital · DEMaastricht University Medical Centre · NL

Funding

Deutsche Forschungsgemeinschaft CRC 1382, project A08
6 · The paper itself

Abstract

Perilipin 2 (PLIN2) is a lipid droplet protein with various metabolic functions. However, studies investigating PLIN2 in the context of inflammation, especially in systemic and acute inflammation, are lacking. Hence, we assessed the relevance of serum PLIN2 in critically ill patients. We measured serum PLIN2 serum in 259 critically ill patients (166 with sepsis) upon admission to a medical intensive care unit (ICU) compared to 12 healthy controls. A subset of 36 patients underwent computed tomography to quantify body composition. Compared to controls, serum PLIN2 concentrations were elevated in critically ill patients at ICU admission. Interestingly, PLIN2 independently indicated multiple organ dysfunction (MOD), defined as a SOFA score > 9 points, at ICU admission, and was also able to independently predict MOD after 48 h. Moreover, serum PLIN2 levels were associated with severe respiratory failure potentially reflecting a moribund state. However, PLIN2 was neither a predictor of ICU mortality nor did it reflect metabolic dysregulation. Conclusively, the first study assessing serum PLIN2 in critical illness proved that it may assist in risk stratification because it is capable of independently indicating MOD at admission and predicting MOD 48 h after PLIN2 measurement. Further evaluation regarding the underlying mechanisms is warranted.

Indexed as

biomarkercritical illnessintensive care unitorgan failureoutcomeprognosissepsisSOFA

Identifiers

PMID34572396
PMCPMC8468514
OpenAlexW3200336678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.